Free Trial

Vicarious Surgical (RBOT) Competitors

Vicarious Surgical logo
$11.29 -1.90 (-14.39%)
Closing price 07/25/2025 03:59 PM Eastern
Extended Trading
$12.69 +1.40 (+12.42%)
As of 07/25/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RBOT vs. MGRM, CV, CVRX, SGHT, TLSI, INGN, PROF, ELMD, RCEL, and LNSR

Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Monogram Orthopaedics (MGRM), CapsoVision (CV), CVRx (CVRX), Sight Sciences (SGHT), TriSalus Life Sciences (TLSI), Inogen (INGN), Profound Medical (PROF), Electromed (ELMD), Avita Medical (RCEL), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry.

Vicarious Surgical vs. Its Competitors

Vicarious Surgical (NYSE:RBOT) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

Monogram Orthopaedics' return on equity of -115.71% beat Vicarious Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Vicarious SurgicalN/A -120.53% -85.51%
Monogram Orthopaedics N/A -115.71%-92.75%

In the previous week, Monogram Orthopaedics had 1 more articles in the media than Vicarious Surgical. MarketBeat recorded 1 mentions for Monogram Orthopaedics and 0 mentions for Vicarious Surgical. Monogram Orthopaedics' average media sentiment score of 1.87 beat Vicarious Surgical's score of 0.00 indicating that Monogram Orthopaedics is being referred to more favorably in the news media.

Company Overall Sentiment
Vicarious Surgical Neutral
Monogram Orthopaedics Very Positive

Vicarious Surgical has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500.

47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 0.5% of Monogram Orthopaedics shares are held by institutional investors. 12.0% of Vicarious Surgical shares are held by company insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Monogram Orthopaedics has higher revenue and earnings than Vicarious Surgical. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vicarious SurgicalN/AN/A-$63.22M-$10.45-1.08
Monogram Orthopaedics$370K547.89-$16.33M-$0.45-12.62

Vicarious Surgical presently has a consensus target price of $8.50, suggesting a potential downside of 24.73%. Monogram Orthopaedics has a consensus target price of $5.40, suggesting a potential downside of 4.93%. Given Monogram Orthopaedics' stronger consensus rating and higher possible upside, analysts clearly believe Monogram Orthopaedics is more favorable than Vicarious Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vicarious Surgical
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Monogram Orthopaedics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

Summary

Monogram Orthopaedics beats Vicarious Surgical on 11 of the 15 factors compared between the two stocks.

Get Vicarious Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RBOT vs. The Competition

MetricVicarious SurgicalMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$78.22M$6.85B$5.70B$21.11B
Dividend YieldN/A1.27%4.60%3.60%
P/E Ratio-1.0825.4528.1028.44
Price / SalesN/A64.09429.3758.65
Price / CashN/A20.5536.2222.92
Price / Book1.434.758.664.69
Net Income-$63.22M$176.14M$3.25B$995.51M
7 Day Performance9.58%2.92%4.22%1.65%
1 Month Performance46.38%3.23%10.51%4.54%
1 Year Performance38.81%7.28%34.40%9.99%

Vicarious Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RBOT
Vicarious Surgical
0.3741 of 5 stars
$11.29
-14.4%
$8.50
-24.7%
+46.6%$78.22MN/A-1.08210Gap Down
High Trading Volume
MGRM
Monogram Orthopaedics
1.0841 of 5 stars
$5.87
+78.4%
$5.40
-8.0%
+126.3%$209.49MN/A-13.0428Gap Up
High Trading Volume
CV
CapsoVision
N/A$4.37
-4.4%
N/AN/A$202.51MN/A0.0090Negative News
Gap Down
CVRX
CVRx
3.0268 of 5 stars
$7.35
+7.6%
$14.50
+97.3%
-12.5%$191.64M$52.87M-3.37160Positive News
SGHT
Sight Sciences
1.408 of 5 stars
$3.70
+8.5%
$4.10
+10.8%
-56.5%$191.28M$78.11M-3.78210Upcoming Earnings
TLSI
TriSalus Life Sciences
2.849 of 5 stars
$4.98
+1.8%
$10.75
+115.9%
-20.1%$188.44M$32.14M-4.45106News Coverage
Positive News
INGN
Inogen
4.2487 of 5 stars
$6.71
-3.0%
$11.00
+63.9%
-29.9%$180.41M$339.96M-5.831,030
PROF
Profound Medical
2.6593 of 5 stars
$5.75
-1.0%
$11.50
+100.0%
-47.9%$172.79M$10.68M-4.71150News Coverage
Positive News
ELMD
Electromed
1.4093 of 5 stars
$19.30
+1.2%
$38.00
+96.9%
+26.9%$161.85M$61.44M25.73160News Coverage
Analyst Forecast
Analyst Revision
RCEL
Avita Medical
1.341 of 5 stars
$5.88
+3.2%
$16.50
+180.6%
-43.4%$155.41M$64.25M-2.68130Positive News
LNSR
LENSAR
1.2718 of 5 stars
$12.90
-1.0%
$15.00
+16.3%
+143.0%$152.09M$53.49M-2.66110Positive News

Related Companies and Tools


This page (NYSE:RBOT) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners